Premier Alternatives

Oligomerix

Bronx, NY · Founded 2006 · Privately Held (backing)

Developer of small molecule therapeutics designed to treat Alzheimer's disease with an upstream approach. Oligomerix is based in Bronx, NY and was founded in 2006. It was valued at $11.1 million at its later-stage round in Mar 2022, the last priced event on record. It has raised $7.7 million across 2 recorded rounds; the latest was a $2.4 million seed round in Mar 2022.

PMV mark · valuation
$11.1M
Oct 2026
Priced at
its later-stage round
Mar 2022
Total raised
$7.7M
Last round
Seed Round
Mar 2022

Oligomerix key facts

as of Oct 2026
  • Developer of small molecule therapeutics designed to treat Alzheimer's disease with an upstream approach.
  • Oligomerix is valued at approximately $11.1M as of Oct 2026, set at its later-stage round, Mar 2022; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $7.7M across 2 recorded rounds; the latest was Seed Round ($2.4M) in Mar 2022.
  • Notable investors include Counterview Capital, Alzheimers Drug Discovery Foundation, Durand Venture Associates, National Institute On Aging, Wheatley Partners.
  • Oligomerix has filed 5 Form Ds with the SEC since 2012, most recently Dec 2024 ($75K sold to 3 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$11.1M

Valued at $11.1M at its later-stage round, Mar 2022. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Oligomerix with a free account
  • ·Watch Oligomerix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Oligomerix funding rounds

2 rounds
Mar 2022Seed Round$2.4MSEC filing▮
Apr 2015Seed Round$400KSEC filing▮
Full funding history →

Oligomerix valuation

Oligomerix was valued at $11.1 million at its later-stage round in Mar 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Oligomerix raised?

Oligomerix has raised $7.7 million in total; 2 of its rounds are on record. The largest on record was a $400,000 seed round in Apr 2015; the most recent was a $2.4 million seed round in Mar 2022.

Oligomerix has filed 5 Form Ds with the SEC since 2012, most recently in Dec 2024 ($75,000 sold to 3 investors).

Oligomerix investors

5 investors are on record for Oligomerix, including Counterview Capital, Alzheimers Drug Discovery Foundation, Durand Venture Associates and National Institute On Aging. The seed round in Mar 2022 drew 12 investors.

About Oligomerix

Developer of small molecule therapeutics designed to treat Alzheimer's disease with an upstream approach. The company specializes in disease-modifying therapeutics for neurodegenerative diseases characterized by aberrant tau protein, ranging from rare tauopathies such as progressive supranuclear palsy and frontotemporal dementia, enabling physicians to treat their patients in an enhanced way.

Sector
Healthcare
HQ
Bronx, NY, United States
Founded
2006
Employees
11
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.